CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhejiang Conba Pharmaceutical Co., Ltd. Company Snapshot
Zhejiang Conba Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Conba Pharmaceutical Co., Ltd. with three other companies in this sector in China: Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2016 sales of 6.18 billion Chinese Renmimbi [US$937.45 million] of which 66% was Chinese Medicine), Zhejiang Medicine Co., Ltd. (5.28 billion Chinese Renmimbi [US$800.90 million] of which 44% was Life Nourishment), and Dong-E-E-Jiao Co Ltd (6.32 billion Chinese Renmimbi [US$958.44 million] of which 89% was Medicine Manufacturing).

Sales Analysis. Zhejiang Conba Pharmaceutical Co., Ltd. reported sales of 6.02 billion Chinese Renmimbi (US$913.26 million) for the year ending December of 2016. This represents an increase of 13.6% versus 2015, when the company's sales were 5.30 billion Chinese Renmimbi. Sales at Zhejiang Conba Pharmaceutical Co., Ltd. have increased during each of the previous five years (and since 2011, sales have increased a total of 184%). Sales of Commerce saw an increase that was more than double the company's growth rate: sales were up 36.2% in 2016, from 1.54 billion Chinese Renmimbi to 2.10 billion Chinese Renmimbi. Not all segments of Zhejiang Conba Pharmaceutical Co., Ltd. experienced an increase in sales in 2016: sales of Value Added Service fell 8.1% to 22.02 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Zhejiang Conba Pharmaceutical Co., Ltd. also experienced decreases in sales in Other (down 0.9% to 14.85 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhejiang Conba Pharmaceutical Co., Ltd.
  Stock Performance Chart for Zhejiang Conba Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/22/2017): 7.09
(Figures in Chinese Renmimbi)
1 Week -1.9%   13 Weeks 2.0%  
4 Weeks 4.4%   52 Weeks 2.9%  
 
Zhejiang Conba Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600572 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 6,019,400,699
(Year Ending Jan 2017).
Employees: 8,632
  Currency: Chinese Renmimbi Market Cap: 17,801,075,700
  Fiscal Yr Ends: December Shares Outstanding: 2,510,730,000
  Share Type: A Gu Closely Held Shares: 1,342,888,833
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.